Federated Hermes’s TELA Bio TELA Stock Holding History

Federated Hermes’s Portfolio TELA Stock Details TELA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-613	Closed	-$1.19K	–	2227
2025 Q2	$1.19K	Buy	613 +50	+9%	+$65	﹤0.01%	1992
2025 Q1	$687	Buy	+563	New	+$1.38K	﹤0.01%	2013
2024 Q3	–	Sell	-712,300	Closed	-$3.35M	–	2162
2024 Q2	$3.35M	Hold	712,300	–	–	0.01%	804
2024 Q1	$4.04M	Hold	712,300	–	–	0.01%	774
2023 Q4	$4.72M	Hold	712,300	–	–	0.01%	740
2023 Q3	$5.7M	Sell	712,300 -3,000	-0.4%	-$27.9K	0.02%	661
2023 Q2	$7.25M	Buy	+715,300	New	+$7.32M	0.02%	615
2020 Q2	–	Sell	-166,940	Closed	-$1.3M	–	2375
2020 Q1	$1.3M	Sell	166,940 -233,060	-58%	-$3.15M	﹤0.01%	1034
2019 Q4	$5.18M	Buy	+400,000	New	+$4.89M	0.01%	764

Other funds holding TELA

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

EWM

Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return

SCM

Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

VCIM

Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Federated Hermes's TELA Position: Q3 2025 in Review

Federated Hermes sold out of TELA Bio (TELA) in Q3 2025, closing a stake of 613 shares — an estimated $1.19K sold.

Federated Hermes first reported a position in TELA in Q4 2019 and held it in 9 quarters. The position peaked at $7.25M in Q2 2023. 40 funds tracked by Wall St. Rank hold TELA as of Q3 2025.

Federated Hermes reported no remaining TELA Bio position as of Q3 2025 after selling out during the quarter.
Federated Hermes sold 613 TELA Bio shares in Q3 2025, an estimated $1.19K.
Federated Hermes first reported a position in TELA Bio in Q4 2019 and held it in 9 quarters.
Federated Hermes's TELA Bio position peaked at $7.25M in Q2 2023.
40 funds tracked by Wall St. Rank held TELA Bio as of Q3 2025.

Based on Federated Hermes's 13F filing for Q3 2025, filed 3 Nov 2025.